Project Number 3U01NS078034-04S1 Agency/Funding Organization NINDS Funding Year 2015 View Full Project Details for BPN14770 PHASE 1 SINGLE ASCENDING DOSE CLINICAL TRIAL IN HEALTHY SUBJECTS Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 7. Early-stage Clinical Drug Development (Phase I and II Clinical Trials) m. Synaptic Plasticity/Neuroprotection Researcher and Organization Principal Investigator GURNEY, MARK E Principal Investigator First Name MARK E Principal Investigator Last Name GURNEY Awardee Organization TETRA DISCOVERY PARTNERS, LLC Awardee State Michigan Contact PI Country United States Project Detail Funding Opportunity Announcement PA-14-077: Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp) FY Overall Cost $694,703 Funding Organization Agency/Funding Organization NINDS Funding Organization Country United States Related Resources Patent Heteroaryl inhibitors of PDE4
